| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2004 | WO2004005459A2 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes |
| 01/15/2004 | WO2004005442A1 Method for the production of conjugated polyunsaturated fatty acids comprising at least two double bonds in plants |
| 01/15/2004 | WO2004005351A2 Neoplasm specific antibodies and uses thereof |
| 01/15/2004 | WO2004005347A1 Thrombin-cleavable factor x analogues |
| 01/15/2004 | WO2004005346A2 Human nuclear hormone receptor |
| 01/15/2004 | WO2004005343A1 Production of transformed plants expressing thyroid stimulating hormone receptor |
| 01/15/2004 | WO2004005340A1 Fusion polypeptide comprising epidermal growth factor and human serum albumin |
| 01/15/2004 | WO2004005339A2 Cationic linear peptides having antibacterial and/or antifungal properties |
| 01/15/2004 | WO2004005335A2 Multimerised growth hormone fusion proteins |
| 01/15/2004 | WO2004005334A2 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 01/15/2004 | WO2004005329A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004005315A2 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 01/15/2004 | WO2004005312A1 Antisense modulation of ptprk expression |
| 01/15/2004 | WO2004005221A2 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | WO2004004769A1 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 01/15/2004 | WO2004004766A1 MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004004760A1 Vaccine for feline infectious peritonitis |
| 01/15/2004 | WO2004004743A1 Immunostimulation by chemically modified rna |
| 01/15/2004 | WO2004004742A1 Improved gm-csf nucleic acid sequences |
| 01/15/2004 | WO2004004687A2 Liposomal vaccine |
| 01/15/2004 | WO2004004495A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2004004447A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/15/2004 | WO2004004445A2 Phytoremediation of contaminant compounds via chloroplast genetic engineering |
| 01/15/2004 | WO2003089591A3 Method of production of soluble and functional large eukaryotic proteins |
| 01/15/2004 | WO2003080794A3 Inhibition of rna function by delivery of inhibitors to animal cells |
| 01/15/2004 | WO2003080648A3 Raav vector compositions and methods for the treatment of choroidal neovascularization |
| 01/15/2004 | WO2003078592A3 Method for the purification, production and formulation of oncolytic adenoviruses |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003070895A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/15/2004 | WO2003066866A3 Cultivation method of transgenic plants for lycopene cyclase |
| 01/15/2004 | WO2003065004A3 Enzyme activation protease assay |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003062450A3 Probe correction for gene expression level detection |
| 01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003059260A3 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 01/15/2004 | WO2003057847A8 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2003054008A3 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 01/15/2004 | WO2003052117A3 Methods and products related to non-viral transfection |
| 01/15/2004 | WO2003045995A3 Cell culture process |
| 01/15/2004 | WO2003033731A3 Methods for detecting ovarian cancer |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003014383A3 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002095032A3 Methods and compositions of human proteins and uses thereof. |
| 01/15/2004 | WO2002092854A3 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 01/15/2004 | WO2002092123A3 Method for induction of genome instability |
| 01/15/2004 | WO2002083844A3 Compositions and methods for the production of betaine lipids |
| 01/15/2004 | WO2002080888A3 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002072607A3 Soluble heterodimeric cytokine receptor |
| 01/15/2004 | WO2002072023A3 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 01/15/2004 | WO2002070736A8 Method for the detection of nucleic acid molecules |
| 01/15/2004 | WO2002066629A9 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 01/15/2004 | WO2002062988A3 Recombination method |
| 01/15/2004 | WO2002061037B1 Administration of nucleic acid sequence to female animal |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002057304A3 Secretory molecules |
| 01/15/2004 | WO2002046470A3 Testing endosymbiont cellular organelles and compounds identifiable therewith |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | US20040010826 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 01/15/2004 | US20040010822 Hydroperoxyde lyases |
| 01/15/2004 | US20040010821 Stress tolerance and delayed senescence in plants |
| 01/15/2004 | US20040010820 Transgenic corn which express ligninolytic enzymes for use in papermaking, waste treatment, bioremediation and pollution control |
| 01/15/2004 | US20040010819 Canola oil having increased oleic acid and decreased linolenic acid content |
| 01/15/2004 | US20040010818 Transgenic plants with a suppressed triterpene level |
| 01/15/2004 | US20040010817 Comprises enzymatic polypeptide for synthesis of fatty acids for use in industrial lubricants, plasticizers and surfactants; vegetable oils |
| 01/15/2004 | US20040010816 Transgenic poa grasses |
| 01/15/2004 | US20040010815 Identification and characterization of plant genes |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010813 Comprises nucleotide sequences capable of heart specific transcription for treating cardiomyopathies and cardiovascular disorders; anticardiopathic agents; drug screening |
| 01/15/2004 | US20040010812 Comprises nucleotide sequences coding receptor for hyaluronic acid mediated motility (RHAMM) for diagnosing, preventing, prognosing and treating tumor disorders; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010810 Producing xenogeneic monocolnal antibody for diagnosis and treatment of cancer, inflammation, allergies and asthma, autoimmune and cardiovascular diseases; immunotherapy |
| 01/15/2004 | US20040010377 Clustering method |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010131 Gramnegative bacterial nucleotide sequences for diagnosing infection and generating disease resistant plants |
| 01/15/2004 | US20040010130 Recombinant gene containing inverted repeat sequence and utilization thereof |
| 01/15/2004 | US20040010124 CD16A binding proteins and use for the treatment of immune disorders |
| 01/15/2004 | US20040010123 Novel cocoa albumin and its use in the production of cocoa and chocolate flavor |
| 01/15/2004 | US20040010119 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009949 Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids |
| 01/15/2004 | US20040009948 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 01/15/2004 | US20040009947 Compounds and methods for enhancing delivery of free polynucleotide |
| 01/15/2004 | US20040009946 Modulation of PTP1B expression and signal transduction by RNA interference |
| 01/15/2004 | US20040009944 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 01/15/2004 | US20040009943 Pathogen vaccines and methods for using the same |
| 01/15/2004 | US20040009942 Administering a polynucleotide having an immunostimulatory sequence comprising the sequence 5'-C, G-3'; a respiratory virus antigen is not administered |
| 01/15/2004 | US20040009940 Gene delivery formulations and methods for treatment of ischemic conditions |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009938 Methods of enhancing renal uptake of oligonucleotides |
| 01/15/2004 | US20040009935 Antisense oligonucleotides, targeted to nucleic acids encoding p21-activated kinase 2, that inhibit the expression of the kinase |
| 01/15/2004 | US20040009934 GM-CSF nucleic acid sequences |
| 01/15/2004 | US20040009916 Purified BMP-2 and BMP-4 proteins used in the treatment of bone and cartilage defects and in wound healing and related tissue repair. |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |